Androgen deprivation therapy exacerbates Alzheimer’s-associated cognitive decline via increased brain immune cell infiltration
Abstract Androgen deprivation therapy (ADT) for prostate cancer is associated with an increased risk of dementia, including Alzheimer’s disease (AD). The mechanistic connection between ADT
